Design Pharma has a unique suite of proprietary technologies that enable the discovery and biosynthetic production of drug candidates.
Design Pharmaceuticals has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in April 2022.
Design Pharmaceuticals's investors include Virtus Inspire Ventures.
Design Pharmaceuticals is headquartered in Cambridge, United States.
Design Pharma has a unique suite of proprietary technologies that enable the discovery and biosynthetic production of drug candidates.
Design Pharmaceuticals is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Design Pharmaceuticals — Funding & Investors." VCBacked, April 12, 2022, https://www.vcbacked.co/company/design-pharmaceuticals. Accessed October 5, 2026.
VCBacked. (2022). Design Pharmaceuticals — Funding & Investors. Retrieved October 5, 2026, from https://www.vcbacked.co/company/design-pharmaceuticals
{{cite web |title=Design Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/design-pharmaceuticals |website=VCBacked |access-date=October 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated